Drug intelligence / Profile preview

Cryo-Cord

Development stage
Unknown
Lead developer
Royal Biologics
Administration
Topical
01

Overview

Cryo-Cord is a cryopreserved, DMSO-free viable placental umbilical cord allograft developed by Royal Biologics for topical application to chronic non-healing wounds, including diabetic foot ulcers. The product is obtained from donated human umbilical cord tissue from healthy mothers undergoing cesarean section delivery, processed aseptically, and preserved with a proprietary cryoprotectant rather than dimethyl sulfoxide. Its intended therapeutic effect is as a soft tissue barrier and wound dressing that delivers structural extracellular matrix and native placental tissue components such as Wharton's Jelly, growth factors, cytokines, and endogenous viable cells to support tissue repair and wound healing. It is a human tissue biologic/allograft rather than a small-molecule or conventional pharmaceutical drug.

Brand names
Cryo-Cord
Other names
DMSO-free viable umbilical cord graftcryopreserved placental umbilical cord allograftumbilical cord allograftumbilical cord product

Beyond the preview

Go deeper on Cryo-Cord.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cryo-Cord.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call